— Know what they know.
Not Investment Advice

NPCE NASDAQ

NeuroPace, Inc.
1W: +3.1% 1M: -4.1% 3M: +13.5% YTD: +7.3% 1Y: -9.5% 3Y: +281.3% 5Y: -22.1%
$16.92
+0.64 (+3.93%)
 
Weekly Expected Move ±9.9%
$12 $14 $15 $17 $18
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 48 · $576.9M mcap · 23M float · 0.899% daily turnover · Short 58% of daily vol

📊 Key Metrics

TTM
$100M
Revenue
+18.1% YoY
$-22M
Net Income
+13.1% YoY
$-10M
Free Cash Flow
+45.8% YoY
81.8%
Gross Margin
-25.2%
Op. Margin
-30.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-159.5%
ROA-21.5%
ROIC-46.0%

Valuation

P/E-26.5
P/B39.5
EV/EBITDA-30.5

Leverage

Debt/Equity3.72
Current Ratio5.28
Interest Cov.-2.7x

Quality Scores

Piotroski F5/9
Altman Z-2.96
Beneish M-3.10

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms